Press release content from Accesswire. The AP news staff was not involved in its creation.
Roscan Gold Appoints Mr. Srinivasan Venkatakrishnan (“Venkat”), Former CEO of AngloGold Ashanti to Board of Directors
February 8, 2021 GMT
TORONTO, ON / ACCESSWIRE / February 8, 2021 / Roscan Gold Corporation (“Roscan” or the “Company”) (TSXV:ROS)(FSE:2OJ)(OTC PINK:RCGCF) is pleased to announce that Mr. Srinivasan Venkatakrishnan (“Venkat”), has joined the Board of Directors of Roscan, as an Independent Non-Executive Director. Venkat a Mining Executive is widely known in the gold sector, where he built an exceptional 30+ year track record leading multinational organizations through transformative change, while fostering and maintaining relationships with investors, financiers, and governments. Venkat brings an exceptional skillset in corporate finance and merger and acquisition (M&A).
Press release content from Business Wire. The AP news staff was not involved in its creation.
Emerging E-commerce Platform Cart.com Welcomes New Chief Growth Officer, Linda Xu
February 8, 2021 GMT
Linda Xu (Photo: Business Wire)
HOUSTON (BUSINESS WIRE) Feb 8, 2021
Cart.com, an end-to-end e-commerce-as-a-service (ECaaS) provider, today announced Linda Xu has been appointed as Chief Growth Officer. She will focus on setting and prioritizing growth goals, both organically and through M&A, and executing strategic initiatives.
Linda Xu (Photo: Business Wire)
Xu brings nearly a decade of experience in finance, strategy and operations. She joins Cart.com from Sitari Ventures, where she served as the Head of Growth for the food and beverage / CPG-focused investment, incubation and operation firm. In her work, she oversaw operations and investments across multiple brands and helped those brands react and stay agile in the everchanging environment of the coronavirus pandemic. Xu’s M&
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
ERYTECH Announces TRYbeCA-1 Phase 3 Trial in 2L Pancreatic Cancer to Continue to Final Analysis
Erytech Pharma S.A.February 8, 2021 GMT ERYTECH Announces TRYbeCA-1 Phase 3 Trial in 2L Pancreatic Cancer to Continue to Final Analysis
The Independent Data Monitoring Committee (IDMC) recommends trial to continue to final analysis, expected in Q4 2021
No safety issues identified, consistent with observations in previous IDMC reviews
Lyon (France) and Cambridge, MA (U.S.), February 8, 2021 – ERYTECH Pharma (Nasdaq & Euronext: ERYP), a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating therapeutic drug substances inside red blood cells, today announced that TRYbeCA-1, a Phase 3 clinical trial evaluating eryaspase in second-line pancrea
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
RotaChrom Technologies Partners With Cyclolab to Increase Production of COVID-19 Treatment
RotaChrom TechnologiesFebruary 8, 2021 GMT
New Partnership Aims to Develop More Efficient, Cost-Effective Process to Purify Remdesivir
Budapest, Hungary, Feb. 08, 2021 (GLOBE NEWSWIRE) via NewMediaWire RotaChrom Technologies, the developer of the world’s first industrial-scale Centrifugal Partition Chromatography (CPC) technology platform, announced today the launch of a collaboration with Cyclolab Cyclodextrin Research and Development Laboratory Ltd. (“Cyclolab″), a cyclodextrin research, development and manufacturing company. This strategic partnership between Cyclolab and RotaChrom aims to develop a more efficient and cost-effective process to purify Remdesivir, which is a widely used treatment option for COVID-19.